Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Open Label?

<< Previous

Bullboard Posts

Next >>

Comment by Garp1on Dec 07, 2022 10:43am

123 Views

Post# 35156167

RE:RE:RE:RE:RE:RE:Open Label?

You think you are mad right now. Option season is coming up soon and i am sure they think they deserve the most out of it at the lowest price possible. I bet you they also believe they attained all their objectives.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price